MondegarAI
Rangeley Capital, LLC

Q3 2025 · 13F-HR

Rangeley Capital, LLCholdings as filed

Filed 2025-11-14 · accession 0000919574-25-006964

$115.6M
Reported value
127
Positions
2025-09-30
Period end
View analyzed profile →PRO

The Brief · Rangeley Capital, LLC · Q3 2025

AI · grounded in 13F

Rangeley Capital, LLC closed its position in Sage Therapeutics Inc SG7, reducing exposure by $6.66M. The fund established new positions in IWM for $4.84M and YEXT for $4.64M. Other activity included a new $3.3M stake in Berto Acquisition Corp and an 11.66% increase in shares of WideOpenWest Inc WOW.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
24665A103DKDELEK US HLDGS INC NEW$6.6M5.75%206,000CommonSOLE
131428104CLMTCALUMET INC$6.0M5.23%331,000CommonSOLE
04335A105ARVNARVINAS INC$5.9M5.13%695,400CommonSOLE
G72800108PRTAPROTHENA CORP PLC$5.5M4.73%560,457CommonSOLE
96758W101WOWWIDEOPENWEST INC$4.9M4.23%948,000CommonSOLE
464287655IWMISHARES TR$4.8M4.19%20,000PUTSOLE
98585N106YEXTYEXT INC$4.6M4.02%545,000CommonSOLE
492327101KROSKEROS THERAPEUTICS INC$4.1M3.54%258,619CommonSOLE
03879J100ABUSARBUTUS BIOPHARMA CORP$3.8M3.30%840,000CommonSOLE
812215200SEGSEAPORT ENTMT GROUP INC$3.5M3.05%154,000CommonSOLE
G1051H101TACOBERTO ACQUISITION CORP$3.3M2.85%317,050CommonSOLE
359678109FLLFULL HSE RESORTS INC$2.9M2.47%891,010CommonSOLE
86881A100SGRYSURGERY PARTNERS INC$2.7M2.32%124,000CommonSOLE
16119P108CHTRCHARTER COMMUNICATIONS INC N$2.5M2.14%9,000CALLSOLE
21874A114CORZWCORE SCIENTIFIC INC NEW$2.4M2.11%136,200CommonSOLE
127537207CDZICADIZ INC$2.4M2.11%516,000CommonSOLE
64110Y108NLOPNET LEASE OFFICE PROPERTIES$2.1M1.80%70,000CommonSOLE
278768106SATSECHOSTAR CORP$1.8M1.52%23,000CommonSOLE
81734D104SEPNSEPTERNA INC$1.7M1.43%88,000CommonSOLE
85512G106STHOSTAR HLDGS$1.5M1.26%177,000CommonSOLE
63900P608NRPNATURAL RESOURCE PARTNERS L$1.3M1.10%12,100CommonSOLE
53635D202LQDALIQUIDIA CORPORATION$1.2M1.00%51,000CommonSOLE
19239V302CCOICOGENT COMMUNICATIONS HLDGS$1.1M0.99%29,700CommonSOLE
760273102RPTXREPARE THERAPEUTICS INC$1.1M0.98%645,876CommonSOLE
126633205UANCVR PARTNERS LP$1.1M0.97%12,496CommonSOLE
50127T109KURAKURA ONCOLOGY INC$1.1M0.92%120,000CommonSOLE
371927104GELGENESIS ENERGY L P$1.0M0.90%62,000CommonSOLE
G4R103107GSR III ACQUISITION CORP$1.0M0.90%100,000CommonSOLE
09225M101BSMBLACK STONE MINERALS L P$1.0M0.89%78,173CommonSOLE
088786108BCYCBICYCLE THERAPEUTICS PLC$1.0M0.87%130,000CommonSOLE
676118201OMEXODYSSEY MARINE EXPL INC$934,9820.81%479,478CommonSOLE
G9R39C103WENNWEN ACQUISITION CORP$851,9020.74%84,180CommonSOLE
83193E102EMSMART SH GLOBAL LTD$845,1000.73%626,000CommonSOLE
G2296A109CCCMUSDCOLUMBUS CIRCLE CAP CORP. I$839,9600.73%83,000CommonSOLE
61225M102GLUEMONTE ROSA THERAPEUTICS INC$837,3300.72%113,000CommonSOLE
58600110975ZSOHO HOUSE & CO INC$824,8200.71%93,200CommonSOLE
G81354105SBXDSILVERBOX CORP IV$806,4730.70%77,027CommonSOLE
282559103ETNBGBP89BIO INC$793,8000.69%54,000CommonSOLE
10922N103BHFBRIGHTHOUSE FINL INC$759,0440.66%14,300CALLSOLE
78574H104SOCSABLE OFFSHORE CORP$733,3200.63%42,000CommonSOLE
34986A104FWRDFORWARD AIR CORP$702,5360.61%27,400CommonSOLE
52634L108LNSRLENSAR INC$679,2500.59%55,000CommonSOLE
G17977110BURBURFORD CAP LTD$657,8000.57%55,000CommonSOLE
G63365103MURAMURAL ONCOLOGY PUB LTD CO$631,3500.55%305,000CommonSOLE
43283X105HGVHILTON GRAND VACATIONS INC$627,1500.54%15,000CommonSOLE
632347100NATHNATHANS FAMOUS INC NEW$599,1030.52%5,410CommonSOLE
78501P203SWKHSWK HLDGS CORP$596,5500.52%41,000CommonSOLE
16119P108CHTRCHARTER COMMUNICATIONS INC N$550,2100.48%2,000CommonSOLE
23292B104HEPSD MARKET ELECTR SVCS & TRADI$538,0000.47%200,000CommonSOLE
810648105SCPHSCPHARMACEUTICALS INC$531,5450.46%93,747CommonSOLE
10922N103BHFBRIGHTHOUSE FINL INC$522,8380.45%9,850CommonSOLE
34986A104FWRDFORWARD AIR CORP$515,3640.45%20,100CALLSOLE
00370M103ABVXABIVAX SA$509,4000.44%6,000CommonSOLE
G7257A105PCAPPROCAP ACQUISITION CORP$485,8120.42%47,304CommonSOLE
G7633M104DRDBROMAN DBDR ACQUISITION CORP$445,7810.39%43,200CommonSOLE
609786108J7JMONOGRAM TECHNOLOGIES INC$440,2500.38%75,000CommonSOLE
N97284108NBISNEBIUS GROUP N.V.$437,8530.38%3,900CommonSOLE
68277Q105OKURONKURE THERAPEUTICS INC$427,5980.37%155,490CommonSOLE
88337F105ODP1THE ODP CORP$427,1350.37%15,337CommonSOLE
36472T109TDAYGANNETT CO INC$413,0000.36%100,000CommonSOLE
G3933N108GTERUGLOBA TERRA ACQUISITION COR$410,7460.36%40,388CommonSOLE
G6717R104OACCOAKTREE ACQUISITION CORP III$397,5620.34%37,827CommonSOLE
G63212107MBAVM3BRIGADE ACQUISITION V CORP$382,0580.33%36,214CommonSOLE
35104E100FDMT4D MOLECULAR THERAPEUTICS IN$370,7590.32%42,665CommonSOLE
G61188127LBTYKLIBERTY GLOBAL LTD$352,5000.31%30,000CommonSOLE
G21301109CCIXCHURCHILL CAPITAL CORP IX$348,2080.30%33,226CommonSOLE
91324P102UNHUNITEDHEALTH GROUP INC$345,3000.30%1,000CommonSOLE
487836108KKELLANOVA$328,0800.28%4,000CommonSOLE
G3415K101FERAFIFTH ERA ACQUISITION CORP I$315,1680.27%30,990CommonSOLE
G6301B101MLACMOUNTAIN LAKE ACQUISITION CO$309,0000.27%30,000CommonSOLE
98262P200WWWW INTL INC$300,9600.26%11,000CommonSOLE
868873100SU6SURMODICS INC$298,9000.26%10,000CommonSOLE
G4863A108BRSLBRIGHTSTAR LOTTERY PLC$293,2500.25%17,000CommonSOLE
640268306NKTRNEKTAR THERAPEUTICS$278,5260.24%4,895CommonSOLE
852312305STAASTAAR SURGICAL CO$268,7000.23%10,000CommonSOLE
G2616F127BCARUD. BORAL ARC ACQ I CORP.$267,9000.23%26,790CommonSOLE
G31249108ESTAESTABLISHMENT LABS HLDGS INC$266,3940.23%6,499CommonSOLE
59267L107METSERA INC$261,6500.23%5,000CommonSOLE
G1827K107CEPOCANTOR EQUITY PARTNERS I INC$261,5000.23%25,000CommonSOLE
10806X102BBIOBRIDGEBIO PHARMA INC$259,7000.22%5,000CALLSOLE
N515171054PKBLAVA THERAPEUTICS NV$257,4000.22%165,000CommonSOLE
G6791A126OTGAUOTG ACQUISITION CORP. I$251,7500.22%25,000CommonSOLE
G2584S135KOYNUCSLM DIGITA ASSET ACQ CORP I$238,3600.21%23,600CommonSOLE
04683R106AVIRATEA PHARMACEUTICALS INC$232,0000.20%80,000CommonSOLE
G7117W123PACHUPIONEER ACQUISITION I CORP$222,6780.19%22,157CommonSOLE
G70077105PCSCPERCEPTIVE CAP SOLUTIONS COR$220,8190.19%20,832CommonSOLE
30329Y304FG NEXUS INC.$219,6000.19%40,000CommonSOLE
G7515A103RDAGREPUBLIC DIGITAL ACQUISITION$204,2000.18%20,000CommonSOLE
87901J105TGNATEGNA INC$203,3000.18%10,000CommonSOLE
713317105PEPGPEPGEN INC$203,2800.18%44,000CommonSOLE
G1051H127TACOUBERTO ACQUISITION CORP$202,4190.18%18,900CommonSOLE
G4569C127HVMCUHIGHVIEW MERGER CORP$202,4000.18%20,000CommonSOLE
285512109EAELECTRONIC ARTS INC$201,7000.17%1,000CALLSOLE
88822Q103TIPTTIPTREE INC$191,7000.17%10,000CommonSOLE
878972108TECXTECTONIC THERAPEUTIC INC$188,2800.16%12,000CommonSOLE
89621C105TMQTRILOGY METALS INC NEW$182,7000.16%87,000CommonSOLE
G3037D121EMMIS ACQUISITION CORP.$180,7980.16%18,107CommonSOLE
21874A106CORZCORE SCIENTIFIC INC NEW$179,4000.16%10,000CommonSOLE
G8316B100SPKLSPARK I ACQUISITION CORP$164,8320.14%14,173CommonSOLE
55083R203LYELLYELL IMMUNOPHARMA INC$162,4000.14%10,000CommonSOLE
46005L101IMXIINTERNATIONAL MNY EXPRESS IN$139,7000.12%10,000CommonSOLE
30334J102FGMCFG MERGER II CORP$135,1940.12%13,531CommonSOLE
G27907107DOLEDOLE PLC$134,4000.12%10,000CommonSOLE
47089W104AIFCALT5 SIGMA CORP$129,9270.11%48,300CommonSOLE
G4365E103HCMAHCM III ACQUISITION CORP$126,6880.11%12,530CommonSOLE
82981J851SITCSITE CTRS CORP$126,1400.11%14,000CommonSOLE
45175G207IMAIMAGENEBIO INC$122,2500.11%15,000CommonSOLE
03748R747AIVAPARTMENT INVT & MGMT CO$118,9500.10%15,000CommonSOLE
G98659108MCGAUYORKVILLE ACQUISITION CORP.$110,5000.10%10,000CommonSOLE
61559X104MLTXMOONLAKE IMMUNOTHERAPEUTICS$107,5500.09%15,000CommonSOLE
G1051H119TACOWBERTO ACQUISITION CORP$104,0000.09%10,000CommonSOLE
729139105PLRXPLIANT THERAPEUTICS INC$89,1260.08%60,220CommonSOLE
037326105ANTXAN2 THERAPEUTICS INC$82,5500.07%65,000CommonSOLE
G1144A105BTBTBIT DIGITAL INC$68,8500.06%22,950CommonSOLE
69353Y103PMVPPMV PHARMACEUTICALS INC$63,7000.06%45,500CommonSOLE
007002108TORCEURADICET BIO INC$60,7650.05%75,000CommonSOLE
84833T103SPROSPERO THERAPEUTICS INC$56,4000.05%30,000CommonSOLE
03212B103AMPYAMPLIFY ENERGY CORP NEW$52,5000.05%10,000CommonSOLE
556099109MGNXMACROGENICS INC$50,7700.04%30,220CommonSOLE
034569103ANEBANEBULO PHARMACEUTICALS INC$50,0000.04%20,000CommonSOLE
76029N106REPLREPLIMUNE GROUP INC$43,5760.04%10,400CommonSOLE
81578P106SEERSEER INC$43,4000.04%20,000CommonSOLE
75120L100RALLYBIO CORP$41,4200.04%83,007CommonSOLE
12674W109CABACABALETTA BIO INC$26,4420.02%11,300CommonSOLE
68236V302ETHZILLA CORPORATION$24,1000.02%10,000CommonSOLE
603380205NERVMINERVA NEUROSCIENCES INC$21,0500.02%10,000CommonSOLE
92941V308VYNEVYNE THERAPEUTICS INC$16,7500.01%50,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.